Table 5.
Psoriatic disease factors and joint pain levels across all follow-up visits among switchers and non-switchers
| Switchers (n = 504) | Non-switchers (n = 4993) | Total (N = 5497) | |
|---|---|---|---|
| PASI/DLQI categories, n (%)b | |||
| PASI ≤ 10 and DLQI ≤ 5 | 217 (5.0) | 4157 (95.0) | 4374 |
| PASI > 10 and DLQI ≤ 5 | 24 (36.4) | 42 (63.6) | 66 |
| PASI ≤ 10 and DLQI > 5 | 188 (20.8) | 715 (79.2) | 903 |
| PASI > 10 and DLQI > 5 | 75 (48.7) | 79 (51.3) | 154 |
| Switchersb (n = 389) | Non-switchersb (n = 3188) | Total (N = 3577) | |
|---|---|---|---|
| PASI/VAS joint painc categories, n (%)b | |||
| PASI ≤ 10 and VAS joint pain < 40 | 104 (4.9) | 2032 (95.1) | 2136 |
| PASI > 10 and VAS joint pain < 40 | 21 (41.2) | 30 (58.8) | 51 |
| PASI ≤ 10 and VAS joint pain ≥ 40 | 208 (16.2) | 1079 (83.8) | 1287 |
| PASI > 10 and VAS joint pain ≥ 40 | 56 (54.4) | 47 (45.6) | 103 |
DLQI Dermatology Life Quality Index, PASI Psoriasis Area and Severity Index, PsA psoriatic arthritis, VAS visual analog scale
aAll eligible follow-up visits were used and the PASI/DLQI recategorized based on these values at follow-up
bPercentage per category indicated
cPatients with a dermatologist diagnosis of PsA at initiation; scores range from 0 to 100 with higher scores indicating worse symptom burden